CCR4 Recombinant Monoclonal Antibody

說明書

中文名稱：

CCR4重組抗體
貨號：

CSB-RA004843MA01HU
規格：

￥1320
圖片：
The Binding Activity of CCR4 with Anti-CCR4 Recombinant Antibody
Activity: Measured by its binding ability in a functional ELISA. Immobilized CCR4 (CSB-MP004843HU) at 10 μg/mL can bind Anti-CCR4 Recombinant Antibody, the EC₅₀ is 362.3-630.8 ng/mL.

Untransfected HEK293 cells surface (green line) and transfected Human CCR4 HEK293 stable cells surface (red line) were stained with anti-CCR4 antibody(2μl/1*10⁶ cells), washed and then followed by FITC-conjugated anti-Human IgG Fc antibody and analyzed with flow cytometry.
其他：

產品詳情
產品評價
相關產品
靶點詳情

產品詳情

產品描述：

CCR4重組單克隆抗體（CSB-RA004843MA01HU）是一種針對人源CCR4靶點的高特異性科研工具。CCR4（C-C趨化因子受體4型）作為G蛋白偶聯受體家族成員，在調節性T細胞（Treg）遷移、Th2細胞介導的免疫反應及腫瘤微環境調控中發揮重要作用，是腫瘤免疫治療和炎癥性疾病研究的關鍵靶點。本抗體通過重組表達技術制備，經ELISA和流式細胞術（FC）嚴格驗證，在FC應用中推薦使用1:50-1:200稀釋比例，可精準識別天然構象的細胞表面CCR4蛋白，展現出優異的批次穩定性和低交叉反應性。實驗數據顯示，該抗體在流式檢測中能清晰區分CCR4陽性和陰性細胞群，適用于免疫細胞分型、腫瘤浸潤淋巴細胞分析以及藥物作用機制研究等場景。配合ELISA平臺使用時，可滿足體外樣本中CCR4蛋白的定量檢測需求，為探索腫瘤免疫逃逸機制、過敏性疾病病理過程及靶向藥物開發提供可靠工具。本產品嚴格限定于科學研究領域，不涉及任何臨床用途。
Uniprot No.：

P51679
基因名：

CCR4
別名：

CCR4; CMKBR4; C-C chemokine receptor type 4; C-C CKR-4; CC-CKR-4; CCR-4; CCR4; K5-5; CD antigen CD194
反應種屬：

Human
免疫原：

Recombinant Human CCR4 protein
免疫原種屬：

Homo sapiens (Human)
標記方式：

Non-conjugated
克隆類型：

Monoclonal
抗體亞型：

hIgG1
純化方式：

Affinity-chromatography
克隆號：

12F5
濃度：

It differs from different batches. Please contact us to confirm it.
保存緩沖液：

Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, PH 7.4
產品提供形式：

Liquid
應用范圍：

ELISA, FC

推薦稀釋比：

Application	Recommended Dilution
FC	1:50-1:200

Protocols：

ELISA Protocol
Flow cytometry (FC) Protocol
儲存條件：

Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
貨期：

Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.
用途：

For Research Use Only. Not for use in diagnostic or therapeutic procedures.

產品評價

靶點詳情

功能：

High affinity receptor for the C-C type chemokines CCL17/TARC, CCL22/MDC and CKLF isoform 1/CKLF1. The activity of this receptor is mediated by G(i) proteins which activate a phosphatidylinositol-calcium second messenger system. Can function as a chemoattractant homing receptor on circulating memory lymphocytes and as a coreceptor for some primary HIV-2 isolates. In the CNS, could mediate hippocampal-neuron survival.
基因功能參考文獻：
1. the expression of chemokine receptors in different peripheral blood T-cell subsets in patients with polymyositis (PM) and dermatomyositis, was examined. PMID: 28869080
2. This review presents key clinical studies of Multiple sclerosis together with experimental studies in animals that have demonstrated functional roles of CCR4, CCL17, and CCL22 in experimental autoimmune encephalomyelitis pathogenesis. [review] PMID: 29099057
3. Taken together, our data showed a likely positive feedback mechanism of enhanced IL-6 production in ectopic milieu. The high levels of IL-6 in the peritoneal cavity stimulate the expression of CCL17 in endometrial stromal cells by activating JNK signal pathway, and then, CCL17 further induces CCR4 expression on macrophages, which eventually leads to an increase in IL-6 production via NF-kappaB activation. PMID: 28240436
4. Investigations showed that the level of CCR4 could be induced by TNF-alpha dependent of NF-kappaB activation in CRC cells. CCR4 might be implicated in TNF-alpha-regulated cancer cells metastasis. PMID: 27356745
5. Tumor-associated macrophages promote prostate cancer migration through activation of the CCL22-CCR4 signaling axis. PMID: 28039457
6. monocyte chemoattractant protein-1 (MCP-1), an endogenous CCR4-binding ligand, was specifically upregulated in the head and neck squamous cell carcinomamicroenvironment compared to the other four CCR4-binding ligands PMID: 27177223
7. A CCR4 antagonist reverses the tumor-promoting microenvironment of renal cancer PMID: 28134623
8. The percentage of CXCR3(+) CD4(+) TEM cells negatively correlated with the severity of the cutaneous disease in psoriasis patients. Importantly CLA(+) CD4(+) TCM cells expressing CCR6(+) or CCR4(+)CXCR3(+) negatively correlated with psoriasis severity suggesting recruitment to the skin compartment. PMID: 28392462
9. Case Report: CCR4+ T-cell depletion by mogamulizumab treatment of adult T-cell leukaemia/lymphoma results in CD8-positive T-cell mediated dermatitis. PMID: 27786349
10. CCL22-specific antibodies reveal that engagement of two distinct binding domains on CCL22 is required for CCR4-mediated function. PMID: 26683175
11. CCR4 mutation is an important determinant of the clinical course in ATLL cases, and that NS and FS mutations of CCR4 behave differently with respect to ATLL pathophysiology. PMID: 26847489
12. Distinctive Treg associated CCR4-CCL22 expression profile with altered frequency of Th17/Treg cell in the immunopathogenesis of Pemphigus Vulgaris. PMID: 26093920
13. Data show that CCR4 was over-expressed in lymph node-negative human gastric cancer tissues and suggest its involvement in promoting tumor invasion probably, through up-regulation of MMP9. PMID: 25790118
14. CCR4 C1014T and CCL22 C16A genetic variations were neither associated with the risk, nor with the progression of colorectal cancer in Iranian population PMID: 25148803
15. Higher percentages of CCR4+ CD4 TEM cells in acute RSV infection were accompanied with higher percentages of CXCR3+ CD8 TEM cells, whereas the development of long-lived memory CXCR3+ CD4 and CD8 TCM cells seems to be compromised PMID: 25013801
16. These findings implicate somatic gain-of-function CCR4 mutations in the pathogenesis of adult T cell leukemia/lymphoma. PMID: 25488980
17. CCR4 has a role in tumor aggressive behavior in renal cell carcinoma PMID: 24554520
18. Data show that CCR4 exists in at least two distinct conformations, which are differentially activated by ligand. PMID: 24563252
19. CCR4 mediates CCL17 induced cell migration via increased total RhoA and active RhoA protein levels in colon cancer cells. PMID: 23649168
20. Anti-CCR4 monoclonal antibody treatment is instrumental for evoking and augmenting antitumor immunity in cancer patients by selectively depleting eTreg cells. PMID: 24127572
21. Authors identify an evolutionarily conserved C-terminal motif in human TTP that directly binds a central domain of CNOT1, a core subunit of the CCR4-NOT complex. PMID: 23644599
22. lymph node metastasis of CCR4(+) HNSCC is promoted by CCL22 in an autocrine or M2-like macrophage-dependent paracrine manner. PMID: 23180648
23. CCR4+ memory T-cell frequency is increased in patients with Wegener's granulomatosis with polyangiitis. PMID: 22490506
24. CCR4-, CCR5-, CXCR3-, and selectin ligand-expressing CD4+ T cells preferentially accumulate in the joints of children with juvenile idiopathic arthritis. PMID: 21739422
25. A high amino acid charge of the envelope glycoprotein 120 V3 region is important for binding to host CXCR4 receptor. PMID: 21525208
26. aberrant expression of CCR4 in human gastric cancer could contribute to tumor-induced immunosuppression. PMID: 21443538
27. Lymphocyte CCR4 expression is closely associated with induction of human allergen-induced late nasal responses. PMID: 20148806
28. high-level lineage-independent induction of CCR4 can occur following T-cell activation without accessibility-associated changes in histone H3, but that without such changes expression is transient rather than persistent. PMID: 20963786
29. We suggest that CCR4 and CCR6 expression on CD4(+) T cells should be considered as markers of disease activity in systemic lupus erythematosus. PMID: 20334681
30. CD4+CD25high Treg cells of Wegener granulomatosis-patients exhibited decreased numbers of cells co-expressing FoxP3 and CCR4 PMID: 20412707
31. CCR4 might play a role in allergen-driven T helper type (Th)2 cell accumulation in asthmatic airways. PMID: 20237293
32. CCR4 ligands secreted by dendritic cells recruit regulatory T cells (Tregs) to sites of inflammation in patients with autoimmune and chronic hepatitis. PMID: 20164417
33. Data show that MDC/CCL22 is present in the synovial membrane of rheumatoid arthritis (RA) and psoriatic arthritis (PsA) patients and in synovial fluid of patients with RA and PsA, which would enable migration of CCR4 expressing memory cells. PMID: 19942450
34. Data show that TH treatment promoted rapid and sustained hCCR4 recruitment to the TH-responsive deiodinase 1 promoter and TR co-localizes with hCCR4 in the nucleus and interacts with hCCR4 in 2-hybrid and pull-down assays. PMID: 19903885
35. CCR4 is expressed with high frequency in adult T-cell leukemia and human T-cell leukemia virus type 1-transformed T cells and in ATL skin lesions. PMID: 11861261
36. CCR4 is mainly expressed by a high cytokine (interleukin-4/interleukin-2)-producing (CD4) subset of natural killer t-cells. PMID: 12070001
37. The skin-homing TH compartment is itself divided into distinct subpopulations, the smaller of which expresses both CCR4 and CCR10, and the larger of which expresses only CCR4. PMID: 12406880
38. CCR4+ cells were present predominantly in the lesional skin of atopic dermatitis patients, but not in the non-lesional skin PMID: 12456591
39. In the blood of cutaneous T cell lymphoma patients with peripheral blood involvement we found significantly increased percentages of T cells displaying the skin-homing phenotype (CLA+CCR4+) compared with healthy individuals. PMID: 12485447
40. Increased expression of CCR4, which is proposed to guide CD25(+) Ts cells to DC, is an intrinsic feature of CD25(+) Ts cells. PMID: 12778466
41. airway allergen-specific T(H)2 cells are CCR4(+), but in the atopic child CCR4 does not distinguish between recall antigen and allergen specificity PMID: 14657875
42. although there is PI(3,4,5)P(3) accumulation downstream of CCR4, phosphoinositide 3-kinase activity is a dispensable signal for CCR4-stimulated chemotaxis of Th2 cells and the CEM T cell line. PMID: 15187160
43. CXCR3 and CCR4 were heterogeneously expressed in peripheral T-cell lymphomas. PMID: 15328188
44. CC chemokine receptor 4 has a role in adult T-Cell leukemia/lymphoma PMID: 15569983
45. review of possible relationship of CCR4 role in T cell migration and skin infiltration in ATL, and of selective expression of CCR4 by Th2 and regulatory T cells and possible origin of ATL in Th2 or regulatory T cells. PMID: 15621800
46. CCR4 and TARC/CCL17 play role in pathophysiology of cutaneous lupus erythematosus(CLE). Cytotoxic CD8+ T cells expressing CCR4 appear to be involved in scarring subtypes of CLE. PMID: 15955100
47. CCR4 and CCR10 may play an important role in ATLL invasion into the skin PMID: 17071491
48. Bexarotene reduces CCR4-positive lymphocytes. PMID: 17546636
49. aberrantly expressed Fra-2 in association with JunD may play a major role in CCR4 expression and oncogenesis in adult T-cell leukemia. PMID: 18071306
50. CCR4 and CCR10 are expressed on epidermal keratinocytes and that both are functional in terms of skin cytokine production and/or migration to their ligand CCL17 and CCL27, respectively. PMID: 18782672
顯示更多

收起更多
亞細胞定位：

Cell membrane; Multi-pass membrane protein.
蛋白家族：

G-protein coupled receptor 1 family
組織特異性：

Predominantly expressed in the thymus, in peripheral blood leukocytes, including T-cells, mostly CD4+ cells, and basophils, and in platelets; at lower levels, in the spleen and in monocytes. Detected also in macrophages, IL-2-activated natural killer cell
數據庫鏈接：

HGNC: 1605

OMIM: 604836

KEGG: hsa:1233

STRING: 9606.ENSP00000332659

UniGene: Hs.184926

Most popular with customers

YWHAG Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC

Species Reactivity: Human
YWHAB Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC, IF, FC

Species Reactivity: Human, Mouse, Rat
Phospho-YAP1 (S127) Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC

Species Reactivity: Human
WFDC2 Recombinant Monoclonal Antibody

Applications: ELISA, WB, FC

Species Reactivity: Human
WDR5 Recombinant Monoclonal Antibody

Applications: ELISA, IHC, FC

Species Reactivity: Human
VIM Recombinant Monoclonal Antibody

Applications: ELISA, IHC, IF

Species Reactivity: Human
VDR Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC

Species Reactivity: Human
VDAC1 Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC

Species Reactivity: Human, Mouse, Rat